Ann: $1.9m Reseach tax incentive received, page-6

It should provide the SP some uplift

If you read the threads, quite a few people were querying whether another CR was required given it was unlikely the 1.1c ALTO's would get converted by February

Now with confirmation of a further $2M cash coming in, there is no CR requirements and it is likely the options will lapse, thus removing a fairly large overhang in the SP

The stock is then free to trade up to 1.4c where the ALTOA's come into play

- WA Governement subsidy deal
- FDA website mentioning the incontinence mesh is dangerous and referring to ALT's pericoach
- $2M R&D rebate and no requirement for CR
The first 2 weren't conveyed to the market, but you can see they are starting to kick some goals

They need to scrub up on their shareholder communications and get this news to market, but I am anticipating higher prices 1-1.4c